diazooxonorleucine and HIV Coinfection

diazooxonorleucine has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alt, J; Brandacher, G; Chao, W; Dash, RP; Furtmüller, G; Gadiano, AJ; Garrett, C; Hadas, E; Jančařík, A; Kelschenbach, J; Kim, BH; Majer, P; Nedelcovych, MT; Oh, B; Prchalová, E; Rais, R; Slusher, BS; Tenora, L; Volsky, DJ; Zimmermann, SC1

Other Studies

1 other study(ies) available for diazooxonorleucine and HIV Coinfection

ArticleYear
N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders.
    Journal of medicinal chemistry, 2017, 08-24, Volume: 60, Issue:16

    Topics: Aminocaproates; Animals; Azo Compounds; Blood; Brain; Diazooxonorleucine; Drug Stability; Female; Glutamic Acid; Glutaminase; HIV Infections; Humans; Male; Mice, Inbred C57BL; Neurocognitive Disorders; Nootropic Agents; Prodrugs; Swine; Viral Load

2017